Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

Core Viewpoint - Anixa Biosciences, Inc. is participating in the Jones Las Vegas Healthcare and Technology Innovation Conference, highlighting its focus on cancer treatment and prevention [1][2]. Group 1: Conference Details - The conference will take place on April 8-9, 2025, at The Venetian Resort in Las Vegas, Nevada [1]. - Mike Catelani, President and CFO of Anixa, will present on April 9, 2025, at 4:30 PM PT and will be available for one-on-one meetings [2]. - The event aims to facilitate direct dialogue between innovative companies and institutional investors through various formats including presentations and networking events [2]. Group 2: Company Overview - Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention, with a therapeutic portfolio that includes an ovarian cancer immunotherapy program developed in collaboration with Moffitt Cancer Center [4]. - The company is also developing vaccines in partnership with Cleveland Clinic to treat and prevent breast and ovarian cancers, as well as other vaccines targeting high incidence malignancies such as lung, colon, and prostate cancers [4]. - Anixa's business model involves partnerships with renowned research institutions, allowing for continuous exploration of emerging technologies for development and commercialization [4].